IMEX   05356
INSTITUTO DE MEDICINA EXPERIMENTAL
Unidad Ejecutora - UE
congresos y reuniones científicas
Título:
THYMIC STROMAL LYMPHOPOIETIN (TSLP) IS A TUMOR MICROENVIRONMENT MODULATOR: RELEVANCE IN THE PATHOGENESIS OF GLIOBLASTOMA AS TUMOR IMMUNOMODULATOR
Autor/es:
CORONEL, JUAN VALENTIN; ROSSO, DAVID ANTONIO; RABADAN, ALEJANDRA T; JANCIC, CAROLINA CRISTINA; ITURRIZAGA, JUAN; SALAMONE, GABRIELA VERÓNICA; INFANTE CRUZ, ALEJANDRA; ROSATO, MICAELA; REMES-LENICOV, FEDERICO
Lugar:
CABA
Reunión:
Congreso; Reunion de Sociedades de Biociencias 2021; 2021
Institución organizadora:
SAIC - SAFICI -SAI
Resumen:
Glioblastoma (GBM) is the most devastating brain tumor, with an others treatments, the survival of GBM patients has not improved significantly in the past three decades. Thymic stromal ymphopoietin (TSLP) is a cytokine produced primarily by activated epithelial cells and it has been shown to be a key factor in maintaining immune homeostasis and regulating inflammatory responses at mucosal barriers. Furthermore, recent studies have found the participation of TSLP in inflammatory diseases and cancer. This work aimed to elucidate the relevance of TSLP in the interaction between neutrophils and GBM cells. For this purpose, human U251 cell line or tumoral cells obtained from a patient?s GBM biopsy (GBM-b) were co-cultured with human neutrophils. First, we observed a decrease in the neutrophils apoptosis when they were cocultured with the U251 cell line or the GBM-b cells in the presence of exogenous TSLP (p